Max Planck Institute for Biochemistry

The Max Planck Institute for Biochemistry (MPIB) is one of Germany’s leading biomedical research institutes, specializing in fundamental research related to molecular mechanisms of life, disease processes, and biological systems. Founded in 1972 and located in Martinsried near Munich, Germany, the institute is part of the Max Planck Society, one of the world’s most respected scientific research organizations.

MPIB conducts pioneering research in areas including molecular biology, structural biology, cell biology, biochemistry, proteomics, genetics, and disease mechanisms. Scientists at the institute study how biological molecules interact and function within cells to better understand health and disease.

The institute operates advanced research facilities equipped with modern technologies such as cryo-electron microscopy, mass spectrometry, molecular imaging, genomics, and computational biology platforms. These resources enable researchers to investigate complex biological processes at molecular levels.

Research at MPIB contributes to understanding diseases including cancer, neurodegenerative disorders, metabolic diseases, and infectious conditions. The institute collaborates with universities, hospitals, pharmaceutical companies, biotechnology organizations, and international research centers.

The Max Planck Institute for Biochemistry follows strict scientific quality standards, laboratory safety requirements, and research ethics principles. It promotes interdisciplinary collaboration and supports young scientists through doctoral and training programs.

With a strong international reputation and decades of scientific achievements, MPIB continues to advance fundamental biomedical knowledge and provide important discoveries that support future developments in medicine, biotechnology, and healthcare innovation.